Chamberlain, Samuel R.
Baldwin, David S. http://orcid.org/0000-0003-3343-0907
Article History
Accepted: 27 May 2021
First Online: 9 July 2021
Change Date: 25 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40263-021-00880-3
Declarations
:
: Prof. Chamberlain’s role in this paper was funded by a Clinical Fellowship from the Wellcome Trust (reference 110049/Z/15/Z and 110049/Z/15/A).
: Prof. Chamberlain previously consulted for Promentis on work not related to MAOIs. He also receives honoraria from Elsevier for editorial work at the journals <i>Neuroscience and Biobehavioral Reviews</i> and <i>Comprehensive Psychiatry</i>. Prof. Baldwin is President-Elect of the BAP and a medical patron of Anxiety UK. He also receives stipends from Wiley for editorial work relating to the journal <i>Human Psychopharmacology</i>.
: Not applicable.
: Professors Baldwin and Chamberlain were both involved in all aspects of manuscript development, from conception to submission.